Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Cancer Research grant will help them develop early detection methods for one of the leading causes of cancer death in the UK.

Image courtesy of P. Lao-Sirieix

Deborah Goberdhan and Elizabeth Bird-Lieberman from the Translational Gastroenterology Unit of the Experimental Medicine Division, John Radcliffe Hospital, have been awarded a Cancer Research UK Primer grant of £100,000 to study ‘Serum extracellular vesicle signatures as biomarkers for non-invasive early detection of oesophageal adencarcinoma’.  

Exosomes are a type of extracellular vesicle, carrying complex mixtures of proteins and other macromolecules, which are key mediators of communication between cancer cells.  

The award builds on the team’s recent identification of novel exosome subtypes and clinical expertise in oesophageal cancer to develop non-invasive early detection methods for this disease, the fifth most common cause of cancer death in the UK.

This grant provides funds to support a Postdoctoral Research Scientist and a part-time Research Technician.  A/Prof Goberdhan and Dr Bird-Lieberman would be happy to receive informal enquiries about these positions by email. 

Similar stories

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

New Pfizer grant paves the way to a better understanding of how body fat is controlled

Professor Ana Domingos has been awarded a highly competitive independent research grant from Pfizer to discover ‘the role of Sympathetic-associated Perineurial barrier Cells in obesity’.